메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 23, Issue 13, 2005, Pages 3158-3159
p53 expression as a prognostic indicator in Hodgkin's lymphoma [5]
Author keywords

[No Author keywords available]
Indexed keywords

PROTEIN BCL XL; PROTEIN P53; TUMOR MARKER;
EID: 19444379513     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.05.159     Document Type: Letter
Times cited : (3)
References (6)
  • 1
    • 2442644270 scopus 로고    scopus 로고
    • Influence of biologic markers on the outcome of Hodgkin's lymphoma: A study by the Spanish Hodgkin's Lymphoma Study Group
    • Montalbán C, Garcia JF, Abraira V, et al: Influence of biologic markers on the outcome of Hodgkin's lymphoma: A study by the Spanish Hodgkin's Lymphoma Study Group. J Clin Oncol 22:1664-1673, 2004
    • (2004) J Clin Oncol , vol.22 , pp. 1664-1673
    • Montalbán, C.1    Garcia, J.F.2    Abraira, V.3
  • 2
    • 0037438584 scopus 로고    scopus 로고
    • Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: Analyses using tissue microarrays
    • Garcia JF, Camacho FI, Morente M, et al: Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: Analyses using tissue microarrays. Blood 101:681-689, 2003
    • (2003) Blood , vol.101 , pp. 681-689
    • Garcia, J.F.1    Camacho, F.I.2    Morente, M.3
  • 3
    • 0031978387 scopus 로고    scopus 로고
    • Low p53 and high bcl-2 expression in Reed-Sternberg cells predicts poor clinical outcome for Hodgkin's disease: Involvement of apoptosis resistance?
    • Brink AA, Oudejans JJ, van den Brule AJ, et al: Low p53 and high bcl-2 expression in Reed-Sternberg cells predicts poor clinical outcome for Hodgkin's disease: Involvement of apoptosis resistance? Mod Pathol 11:376-383, 1998
    • (1998) Mod Pathol , vol.11 , pp. 376-383
    • Brink, A.A.1    Oudejans, J.J.2    van den Brule, A.J.3
  • 4
    • 0034103158 scopus 로고    scopus 로고
    • Prognostic factors in Hodgkin's disease: Multivariate analysis of 327 patients from a single institution
    • Smolewski P, Robak T, Krykowski E, et al: Prognostic factors in Hodgkin's disease: Multivariate analysis of 327 patients from a single institution. Clin Cancer Res 6:1150-1160, 2000
    • (2000) Clin Cancer Res , vol.6 , pp. 1150-1160
    • Smolewski, P.1    Robak, T.2    Krykowski, E.3
  • 5
    • 0028356435 scopus 로고
    • Expression of the p53 gene in Hodgkin's disease: Dissociation between immunohistochemistry and clinicopathological data
    • Xerri L, Bouabdallah R, Camerlo J, et al: Expression of the p53 gene in Hodgkin's disease: Dissociation between immunohistochemistry and clinicopathological data. Hum Pathol 25:449-454, 1994
    • (1994) Hum Pathol , vol.25 , pp. 449-454
    • Xerri, L.1    Bouabdallah, R.2    Camerlo, J.3
  • 6
    • 0030801898 scopus 로고    scopus 로고
    • Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression
    • Morente MM, Piris MA, Abraira V, et al: Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression. Blood 90:2429-2436, 1997
    • (1997) Blood , vol.90 , pp. 2429-2436
    • Morente, M.M.1    Piris, M.A.2    Abraira, V.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.